Tagreed Alkaltham: WB Donation vs Apheresis Donation – Understanding Donor Reactions and Why They Differ
Tagreed Alkaltham, Transfusion Medicine Lab Supervisor at KSMC, shared a post on LinkedIn:
“Whole Blood Donation vs Apheresis Donation
Understanding Donor Reactions and Why They Differ
Not all donation reactions happen for the same reason. And not all donation procedures affect the body in the same way. That distinction matters.
Because whole blood donation and apheresis donation are fundamentally different processes physiologically, even though both are performed within structured donor safety systems.
In whole blood donation:
A unit of blood is collected directly from the donor over a relatively short period of time.
The most common donor reactions are often related to:
- temporary blood volume reduction
- vasovagal responses
- dehydration
- fatigue
- or local needle site reactions such as bruising
Some donors may experience:
- dizziness
- lightheadedness
- nausea
- sweating
- temporary weakness
Most reactions are mild and self limited.
In apheresis donation:
Blood continuously circulates through an extracorporeal circuit while selected components are collected and the remaining components are returned to the donor.
Because the procedure is different, the physiologic considerations are also different.
Apheresis reactions may involve:
- citrate related symptoms
- tingling sensations
- chills or shivering
- muscle twitching or cramping
- vascular access discomfort
- or prolonged procedural fatigue in some donors
These reactions are often associated with:
- anticoagulant exposure
- extracorporeal circulation
- procedure duration
- and continuous collection return cycles.
This does not mean one procedure is ‘good’ and the other is ‘bad.’
And it does not mean one donor reaction profile automatically makes one approach universally safer than the other. Each procedure has different physiologic considerations, monitoring priorities, and donor suitability requirements.
That is why donor selection, procedural monitoring, staff training, and communication remain essential in both settings.
The most important principle is this:
Safety in donation is not defined by the complete absence of physiologic reactions.
It is defined by:
- anticipating reactions
- recognizing them early
- responding appropriately
- and continuously improving donor care systems.
Because responsible donation programs are not built on perfect physiology. They are built on preparation, vigilance, and professional response.
The safest donation process is not the one with zero physiologic impact. It is the one where donor reactions are understood, monitored, and managed appropriately.”

Other posts featuring Tagreed Alkaltham on Hemostasis Today.
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?